|
What is the OssaTron?
The OssaTron is a high energy shockwave system that provides a non-invasive surgical alternative for patients diagnosed with chronic proximal plantar fasciitis (severe heel pain). This non-invasive out-patient procedure represents a breakthrough treatment of this condition.
Using a unique process known as orthopedic extracorporeal shock wave surgery with the OssaTron (Orthotripsy), the device emits shock waves, similar to those used to treat kidney stones, to increase blood flow and stimulate healing of the affected heel.
What Are The Expected Results?
Orthotripsy with the OssaTron has been proven to be effective over 80% of the time with only one treatment. Some patients report immediate pain relief after the procedure, although it can take up to four weeks for pain relief to begin.
Is It Safe?
Yes. Developed in 1991 and widely used in Europe, the OssaTron is the first ESW extracorporeal shock wave device specifically designed and FDA-approved for orthopedic use. A wealth of medical experience, state-of-the-art engineering and optimal quality have been built into the OssaTron, and extensive clinical studies and tests have confirmed its safety and efficacy.
Why Consider Non-invasive ESW with the OssaTron Versus Surgery?
Many times, invasive surgery leads to the development of thick scar tissue and a recurrence of equal or greater pain in the affected heel. Post-surgical protocol can be four weeks or more of zero weight bearing followed by casting and therapy. Total time for recovery and maximum medical improvement can be as much as a year.
ESW with the OssaTron device has a proven success rate that is equal to or greater than that of surgery-usually with just one procedure and without the inherent risks, complications and lengthy recovery time of invasive surgery. ESW with the OssaTron requires a minimal amount of time and patients can go home the same day the procedure is performed. Patients can bear weight (i.e., walk) immediately and return to normal activity within a few days of the procedure.
Who Should Not Have ESW Procedure with the OssaTron?
The ESW procedure is not recommended for anyone who is taking medications for bleeding problems or has a history of bleeding or blood clotting problems, children, or pregnant women.
|
Prior to administering anesthesia, the physician palpates the heel to determine the area of maximum tenderness (target tissue) and marks the area with a surgical marking pen. Once this has been completed, physician administers the form of anesthesia (either local or regional) he/she feels patient appropriate.
Once anesthesia has been administered, high viscosity ultrasound gel is applied to the area previously marked with the surgical marking pen (target tissue). The gel promotes shockwave conductance, enhancing treatment effectiveness.
The patient's heel is firmly coupled to treatment head.
The OssaTron Application Technician activates the shock wave via the shockwave release hand piece on the console.
|
